Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-31

Clinical Trial Update: The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating intracavernosal umbilical cord mesenchymal stem cell implantation for erectile dysfunction in diabetes; status unavailable.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • umbilical cord mesenchymal stem cells (intracavernosal implantation)

Snippet

Sponsor: Indonesia University | Conditions: Urologic Diseases, Erectile Dysfunction With Diabetes Mellitus | Phase 2, Phase 3 | Status: UNKNOWN